Maternal diabetes significantly increases the risk of congenital malformation, a syndrome known as diabetic embryopathy. Nitric oxide (NO), implicated in embryogenesis, has been found elevated in embryos from diabetic rats during organogenesis. The developmental signaling molecules endothelin-1 (ET-1) and 15-deoxy D 12,14 prostaglandin J 2 (15dPGJ 2 ) downregulate embryonic NO levels. In the presence of NO and superoxide, formation of the potent oxidant peroxynitrite may occur. Therefore, we investigated peroxynitrite-induced damage, ET-1 and 15dPGJ 2 concentrations, and the capability of ET-1, 15dPGJ 2 and prostaglandin E 2 (PGE 2 ) to regulate NO production in embryos from severely diabetic rats (streptozotocin-induced before pregnancy). We found intense nitrotyrosine immunostaining (an index of peroxynitrite-induced damage) in neural folds, neural tube and developing heart of embryos from diabetic rats (P < 0.001 vs controls). We also found reduced ET-1 (P < 0.001) and 15dPGJ 2 (P < 0.001) concentrations in embryos from diabetic rats when compared with controls. In addition, the inhibitory effect of ET-1, 15dPGJ 2 and PGE 2 on NO production found in control embryos was not observed in embryos from severely diabetic rats. In conclusion, both the demonstrated peroxynitrite-induced damage and the altered levels and function of multiple signaling molecules involved in the regulation of NO production provide supportive evidence of nitrosative stress in diabetic embryopathy. Reproduction (2005) 130 695-703 
Introduction
Diabetes mellitus profoundly alters reproductive function, thus resulting in increased spontaneous abortion, congenital anomalies and neonatal morbidity/mortality rates (Schwartz & Teramo 2000) . The frequency of congenital malformations in the offspring of diabetic mothers is estimated to be 5 -12%, compared with 2 -3% in the nondiabetic population (Kitzmiller et al. 1978 , Langer & Conway 2000 . The malformations in offspring of diabetic women and also in experimental diabetic models most often occur in the heart and the central nervous system (Eriksson et al. 1991 , Martínez-Frias 1994 . The precise pathogenesis of the development caused by maternal diabetes is complex, has multiple origins and is not understood in full. Increased oxidative stress, alterations in prostaglandin formation, increased formation of glycated proteins and increased apoptotic rate have been proposed as possible explanations for diabetes-induced congenital defects (Reece et al. 1998 , Eriksson et al. 2003 , Horal et al. 2004 . In addition, we have previously demonstrated that nitric oxide (NO) production is elevated in the embryos from mild and severe diabetic rat models during early organogenesis (Jawerbaum et al. 1998 (Jawerbaum et al. , 2001 .
NO is a versatile signal molecule implicated in several physiological and pathological processes (Moncada et al. 1991) . NO is produced from L-arginine in almost all cell types by a family of three nitric oxide synthases (NOS) and acts as a diffusible short-distance acting second messenger that can freely pass through lipid membranes (Moncada et al. 1991) . Several studies have shown that NO is produced in the oocyte stage and throughout early embryo development and is involved in oocyte maturation, ovulation, fertilization and implantation (overviewed by Thaler & Epel 2003) . In addition, studies support an important role for NO in post-implantation embryo development, probably regulating cell survival, apoptosis and differentiation in a time-and space-dependent manner needed throughout organogenesis. This is suggested by changes in the pattern of NOS expression during organogenesis (Topel et al. 1998 , Young et al. 2002 , embryonic heart defects and cardiomyocyte apoptosis in endothelial NOS knockout mice (Feng et al. 2002) , apoptotic effects of both NOS inhibitors and NO donors in cephalic morphogenesis (Lee & Juchau 1994 , Plachta et al. 2003 , and differentiation effects of NO during lung branching morphogenesis (Young et al. 2002) . As NO synthesis and function are critical during embryo development, multiple regulatory pathways are likely to control the appropriate NO concentrations required to ensure normal embryo development.
Our previous studies have demonstrated the capability of endothelin-1 (ET-1) and 15-deoxy D 12,14 prostaglandin J 2 (15dPGJ 2 ) of regulating NO production in the embryo during organogenesis . ET-1 is a potent vasoconstrictor peptide originally isolated from cultured endothelial cells (Yanagisawa et al. 1988 ) that plays an important role in embryo organogenesis, as demonstrated by craneofacial, great vessel, heart, thyroid and thymus congenital defects seen in ET-1 knockout mice (Kurihara et al. 1994) or as a result of ET-1 receptor blockage (Treinen et al. 1999) . We have previously found that ET-1 is a negative regulator of NO concentrations in the embryo from control and mild diabetic rats during embryo organogenesis . On the other hand, 15dPGJ 2 is a cyclopentenone prostaglandin (PG) synthesized by non-enzymatic dehydration within the cyclopentane ring of PGD 2 (Straus & Glass 2001) . In contrast to classical prostaglandins, which bind to cell surface G protein-coupled receptors, 15dPGJ 2 lacks cell surface receptors but possesses a reactive a,b-unsaturated carbonyl functional group that binds free sulphydryl groups of cysteine residues in cellular proteins and regulates the activity of nuclear receptors and nuclear factors such as peroxisome proliferator-activated receptor gamma (PPARg) and nuclear factor kappa B (NFkB) (Kliewer et al. 1995 , Rossi et al. 2000 . 15dPGJ 2 has potent anti-inflammatory properties and represses the genes encoding proinflammatory cytokines and inducible NOS (Ricote et al. 1998) . We have previously found that 15dPGJ 2 is a negative regulator of NO levels in the embryo from control and mild diabetic rats during embryo organogenesis . NO concentrations have also been found to be regulated by PGE 2 in different tissues (Paliege et al. 2004 , Sakamoto et al. 2004 . On the other hand, NO is a positive regulator of PGE 2 concentrations during embryo organogenesis in both control and mild diabetic rats (Jawerbaum et al. 1998) . Indeed, impairment of NO positive regulation leads to reduced PGE 2 levels in the embryo from severely diabetic rats, an alteration that has been related to the increased diabetes-induced neural tube defects (Piddington et al. 1996 , Jawerbaum et al. 2001 . This impairment of NO biological function leading to low intraembryonic PGE 2 levels seems to be directly related to the increased reactive oxygen species (ROS) generated in the embryo under hyperglycemic conditions . Indeed, NO may turn biologically inactive due to its interaction with ROS, leading to the formation of the potent oxidant peroxynitrite (Beckman et al. 1990) . The peroxynitrite anion is highly cytotoxic because it inhibits mitochondrial electron transport, oxidizes sulphydryl groups in proteins, initiates lipid peroxidation, and nitrates amino acids such as tyrosine, thus affecting many signal transduction pathways (overviewed by Szabó 2003) . In the presence of peroxynitrite, formation of nitrotyrosine is particularly favored, and the appearance of this product in biological samples is taken as a diagnosis of exposure of peroxynitrite (Greenacle & Ischiropoulos 2001) .
In the present work we investigated evidence of peroxynitrite-induced damage, levels of the embryonic developmental signals ET-1 and 15dPGJ 2 , and the capability of ET-1, 15dPGJ 2 and PGE 2 to downregulate the elevated NO concentrations in the embryo from severely diabetic rats. We demonstrated peroxynitrite-induced damage, reduced ET-1 and 15dPGJ 2 concentrations and impairment of multiple NO regulatory pathways in embryos from this experimental diabetic model.
Materials and Methods

Animals
Albino Wistar rats bred in the laboratory were fed Purina rat chow, which was available ad libitum. Female rats weighing 200-230 g were made diabetic with a single i.p. injection of streptozotocin (55 mg kg 21 ) (Sigma, St Louis, MO, USA) in citrate buffer (0.05 M, pH 4.5), as previously described (Jawerbaum et al. 2001) . Control rats were injected with buffer only. Diabetic rat glycemia was measured five days after treatment by glucostix reagent strips (Bayer Diagnostics, Buenos Aires, Argentina) and a glucometer. Estrous cycles in diabetic rats were observed throughout the two weeks after streptozotocin administration, and during this period they became pregnant if mated. Both normal and diabetic females were mated with control male rats. Mating was confirmed by the presence of sperm in vaginal smears. When a positive pregnancy was identified, this was designated day 0.5 of gestation. The guidelines for the care and use of animals approved by the local institution were followed, and accorded with the guidelines set out in Principles of Laboratory Animal Care (NIH publication no. 85 -23, revised 1985) .
Embryo preparations
Animals were killed by cervical dislocation on day 10.5 of pregnancy and the uteri were transferred to Petri dishes with Krebs Ringer bicarbonate (KRB) solution: 11.0 mM glucose, 145 mM Na . By use of a stereomicroscope and watchmaker forceps the balls of decidual tissue were removed from each uterus, and gently opened to free the conceptuses. The embryos were dissected out of the yolk sacs and evaluated morphologically under a stereomicroscope. Viability was established by the presence of a beating heart. The embryos were categorized as morphologically normal or as showing either neural tube defects or other malformations. Embryonic growth was quantified by direct measurement of the protein content (Bradford 1976) with bovine seroalbumin as a standard. Embryos in resorption stages received no further analyses. Two embryos from each mother were selected at random for immunohistochemical analysis, fixed in 4% formalin, subsequently dehydrated in graded ethanol, transferred to xylene and finally embedded in paraffin. The remaining embryos were stored at 2 70 8C for measurement of ET-1 and 15dPGJ 2 concentrations or incubated as follows: four embryos were incubated together in a metabolic shaker, under an atmosphere of 5% CO 2 in 95% O 2 at 37 8C for 1 h in 1 ml KRB with or without the addition of ET-1 10 27 M (Sigma), 15dPGJ 2 2 £ 10 26 M (Cayman Chemical Co., Ann Harbor, MI, USA) or PGE 2 10 27 M (Sigma). After incubations, embryos were stored at 2 70 8C until determination of nitrate/nitrite concentrations.
Nitrotyrosine localization
Immunostaining of nitrotyrosine, an index of peroxynitrite-induced damage was performed as previously described . Briefly, paraffinized embryos from six control and six diabetic rats were sliced in 5 mm-thick sections. Thereafter, the slides were deparaffinized and endogenous peroxidase activity was blocked by incubation in 0.5% hydrogen peroxide in absolute methanol for 30 min at room temperature. Then, sections were rehydrated through a graded series of ethanol and were processed using the nitrotyrosine mouse monoclonal antibody (Calbiochem, La Jolla, CA, USA) (1:200 dilution) as primary antibody and the peroxidase anti-peroxidase technique (PAP), as follows. Sections were incubated in 10% normal goat serum (Sigma) for 1 h at room temperature, and then incubated in the primary antibody for 48 h at 4 8C. Later, sections were incubated in goat anti-mouse secondary antibody (Sigma) (1:50 dilution) for 1 h at room temperature and mouse PAP (Sigma) (1:100 dilution) for 1 h at room temperature. All antibodies were diluted in PBS containing 0.2% Triton X-100. Color development was performed with a solution containing 0.06% 3,3 0 diaminobenzidine (DAB) (Sigma) plus 0.01% hydrogen peroxide in Tris saline buffer for 15 -30 min. Control sections were performed by omitting the primary antibody. After color development, sections were counterstained with hematoxylin. Sections were dehydrated, mounted with Entellan New (Merck, Darmstadt, Germany) and observed with a Zeiss Axiophot light microscope.
Image analysis
Optical density of nitrotyrosine residues in the embryonic slides was measured in an Axiophot Zeiss light microscope equipped with a video camera on line with a Zeiss-Kontron VIDAS image analyzer. The resolution of each pixel was 256 gray levels. For each experimental condition, the analysis was performed in six embryonic sections from six control and six diabetic rats. Optical density was evaluated in an area of 120 mm 2 ten times per section.
Nitrate/nitrite determinations
Embryonic concentrations of nitrates and nitrites, stable metabolites of NO, were quantified by employing an assay kit for nitrate and nitrite determinations (Assay Design Inc., Ann Arbor, MI, USA). The embryos were sonicated in Tris hydrochloride buffer solution pH 7.4, and an aliquot separated for protein determination.
Nitrates in the supernatant were reduced to nitrites using nitrate reductase, and total nitrites were measured by the Griess reaction (Green et al. 1982) . Optical densities were measured at 540 nm in a microtiter plate using sodium nitrite and sodium nitrate as standards. Results are expressed in nmol mg protein
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.
Endothelin-1 analysis
ET-1 was measured in control and severely diabetic embryos by employing an ET-1 enzyme immunoassay (EIA) kit (Cayman Chemical Co.). Four embryos were sonicated in 250 ml 6% acetic acid and extraction of samples was performed on Sep-Pack C18 cartridges pretreated with 5 ml methanol and 5 ml acidified water at pH 3.0. After washing with 10 ml 0.1% trifluoroacetic acid, endothelins were eluted with 3 ml methanol/water/trifluoroacetic acid (90/10/0.1). The cartridge eluates were evaporated and the resulting dried residues were resuspended in phosphate-buffered saline (PBS), pH 7.2 for subsequent EIA measurements. Briefly, the kit uses a monoclonal antibody to ET-1 and is based on a double-antibody technique. Each well of the microtiter plate was coated with the ET-1 antibody, which binds the ET-1 introduced in the well. An acetylcholinesterase:endothelin Fab' conjugate was also added to the well, allowing the two antibodies to bind on opposite sides of the ET-1 molecule. The concentration of ET-1 was determined by measuring the enzymatic activity of the acetylcholinesterase by the addition of Ellman's reagent (Caymen Chemical Co.) and measurement of the yellow-colored product on a microplate reader at 412 nm. separated for protein determination, and embryonic prostaglandins were extracted twice in absolute ethanol. The extracts were dried in a Savant (Hicksville, NY, USA) Speed-Vac concentrator and they were reconstituted with 50 ml ethanol and 200 ml assay buffer provided by the commercial kit. Briefly, the kit uses a polyclonal antibody to 15dPGJ 2 to bind, in a competitive manner, the prostaglandin in the sample or an alkaline phosphatase molecule that has 15dPGJ 2 covalently attached to it. After a simultaneous incubation, a p-nitrophenyl phosphate substrate is added, and the yellow color generated is evaluated on a microplate reader at 405 nm. Results are expressed as pg mg protein
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Statistical analyses
All data are presented as the mean^S.E.M. Statistical analyses were performed by employing Student's t-tests, chi-square tests or one-way analysis of variance in conjunction with the Tukey's test where appropriate. Differences between groups were considered significant when P, 0.05.
Results
Gycemia in diabetic rats and morphological characteristics of the embryos from control and severely diabetic rats Glycemia in the diabetic rat females was greatly elevated (P , 0.001) when compared with controls (Table 1) . Embryos obtained from diabetic rats at day 10.5 of gestation showed increased resorption rate (P , 0.001), reduced somite number (P , 0.05) and diminished protein content (indicating growth delay, P , 0.01), when compared with embryos from control rats (Table 1) . Embryonic malformations, mainly in the neural tube and developing heart, were increased (P , 0.001) when compared with embryos from controls (Table 1) .
Peroxynitrite-induced damage in embryos from control and severely diabetic rats
In order to characterize peroxynitrite-induced damage, the localization of nitrotyrosine residues was evaluated by immunohistochemistry in embryonic slides from control and diabetic rats on day 10.5 of gestation (Fig. 1) . Absence of nitrotyrosine immunostaining was observed in both the cephalic and heart regions of the developing control embryos (Fig. 1A and B) . In contrast, a strong nitrotyrosine immunoreactivity was detected in the closing neural folds (cephalic region, Fig. 1C) , and in the developing heart, primitive digestive tube and neural tube (heart region, Fig. 1D ) of the embryos from diabetic rats. Densitometric analysis of the slides showed that the staining was higher in both the cephalic (P , 0.001) and the heart (P , 0.001) sections of the embryos from diabetic rats when compared with controls (Table 2 ). In the absence of primary antibody, no immunostaining was observed in embryonic slides of control and diabetic rats (data not shown).
ET-1 concentrations and the effect of ET-1 on nitrate/nitrite concentrations in embryos from control and severely diabetic rats
The concentrations of ET-1 were decreased in the embryos from severely diabetic rats when compared with controls (56%, P , 0.001) ( Fig. 2A) . Embryos obtained from control and severely diabetic rats on day 10.5 of gestation were incubated for 1 h in the presence or absence of ET-1 10 27 M, and nitrate/nitrite concentrations were then evaluated (Fig. 2B) . In embryos from severely diabetic rats, nitrate/nitrite concentrations were increased when compared with controls (146%, P , 0.001). The presence of ET-1 diminished the embryonic nitrate/nitrite concentrations in embryos from control rats (29%, P , 0.05) but did not modify NO production in embryos from severely diabetic rats (Fig. 2B) . 15dPGJ 2 concentrations and the effect of 15dPGJ 2 on nitrate/nitrite concentrations in embryos from control and severely diabetic rats
The concentrations of 15dPGJ 2 were dramatically decreased in the embryos from severely diabetic rats when compared with controls (92%, P , 0.001) (Fig. 3A) . Embryos obtained from control and severely diabetic rats on day 10.5 of gestation were incubated for 1 h in the presence or absence of 15dPGJ 2 2 £ 10 26 M, and nitrate/nitrite concentrations were then evaluated (Fig. 3B) . The presence of 15dPGJ 2 2 £ 10 26 M diminished the embryonic nitrate/nitrite concentrations in embryos from controls (21%, P , 0.05), but was not able to reduce the high NO levels in the embryos from severely diabetic rats (Fig. 3B) .
Effect of PGE 2 on nitrate/nitrite concentrations in embryos from control and severely diabetic rats
The concentrations of PGE 2 have been found to be reduced in the embryos from severely diabetic rats (Jawerbaum et al. 2001) . Embryos obtained from control and severely diabetic rats on day 10.5 of gestation were incubated for 1 h in the presence or absence of PGE 2 10 27 M, and nitrate/nitrite concentrations were then evaluated (Fig. 4) . The presence of PGE 2 diminished the embryonic nitrate/nitrite concentrations in embryos from control rats (27%, P , 0.05), but did not modify the elevated NO levels found in the embryos from severely diabetic rats (Fig. 4) .
Discussion
The embryonic malformation rate is clearly dependent on hyperglycemia levels, as found in human diabetic pregnancies, in in vitro culture of rodent embryos in hyperglycemic conditions and in diabetic experimental models (Miller et al. 1988 , Eriksson et al. 1991 .
The present work is the first to show peroxynitriteinduced damage in the embryo from diabetic mothers. Indeed, an intense nitrotyrosine immunostaining was detected in the neural folds, neural tube and developing heart of embryos from severely diabetic rats, whereas no immunostaining for nitrotyrosine was detected in control embryos. Peroxynitrite-induced damage has previously been found in different diabetic tissues, including the placenta from diabetic patients and diabetic rats (Lyall et al. 1998 . Peroxynitrite formation in the embryo from diabetic rats is probably the result of increased NO, increased ROS and diminished antioxidants (Jawerbaum et al. 2001 , Eriksson et al. 2003 , and is probably related to the increased apoptotic rate, reduced antioxidant capacity and increased malformation rate found in this pathology. Indeed, peroxynitrite, formed by the interaction of NO with superoxide anion, is more cytotoxic than NO and than superoxide in a variety of experimental conditions (overviewed by Szabó 2003). In addition to being a terminal mediator of cell injury, peroxynitrite enhances and triggers a variety of pro-inflammatory processes, and impairs antioxidant systems. For instance, tyrosine nitration leads to dysfunction of nitrated proteins, as has been shown in the case of superoxide dismutase and prostacyclin synthase (Yakamura et al. 1998 , Zou et al. 2002 . Peroxynitrite mediates the depeletion of glutathione, one of the key cellular antioxidants Figure 1 Representative photomicrographs of transverse sections from embryos obtained from control (A and B) and severely diabetic rats (C and D) on day 10.5 of gestation showing cephalic (A and C; NF, neural folds) and heart (B and D; CT, cardiac tube; NT, neural tube; DT, digestive tube) regions immunostained for nitrotyrosine. Observe the intense immunostaining of nitrotyrosine in both the cephalic and heart regions in the embryos from diabetic rats (C and D) compared with control images (A and B). Original magnification: £ 800. Table 2 Optical density (O.D.) analysis of nitrotyrosine residues in embryos from control and severely diabetic rats. Values are means^S.E.M. from six embryos from control rats and six embryos from diabetic rats (60 determinations per experimental condition).
Control Diabetic
Cephalic region Heart region Cephalic region Heart region Nitrotyrosine (O.D.) 0.12^0.007 0.10^0.008 0.19^0.009* 0.23^0.01** *P , 0.001 compared with control (cephalic region), **P , 0.001 compared with control (heart region) (ANOVA).
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www.reproduction-online.org Reproduction (2005) 130 695-703 (Cuzzocrea et al. 1998) . Peroxynitrite also oxidizes critical sulphydryl groups responsible for the inhibition of critical enzymes in the mitochondrial respiratory chain (Hausladen & Fridovich 1994) . In addition, peroxynitritemodified cellular proteins are subject to accelerated degradation via the proteosome (Grune et al. 1998) . Peroxynitrite can also activate the nuclear enzyme poly(ADPribose) polymerase (PARP), which can trigger a cellular suicide pathway (Szabó et al. 1997) . Due to the powerful capability of inducing multiple derangements, the intense peroxynitrite-induced damage found in the embryos from severely diabetic rats may suggest that peroxynitrite is one of the central mechanisms through which badly controlled diabetes induces embryo loss and congenital malformations.
Evidence of the effect of the multiple damage induced by peroxynitrite may be the observed lack of regulatory pathways of ET-1, 15dPGJ 2 and PGE 2 in the embryo from severely diabetic rats. Indeed, these agents down-regulated NO production in the embryos from control and mildly diabetic rats , but not in the embryos from severely diabetic rats, an alteration probably leading to a sustained NO production and further formation of peroxynitrite. Peroxynitrite formation may also impair NO bioavailability and thus its physiological functions, as suggested by the impaired effect of NO as a regulator of both PGE 2 production in oocytes and embryos from severely diabetic rats and murine yolk vasculogenesis under hyperglycemic conditions, even when NO is overproduced (Jawerbaum et al. 1999 , Nath et al. 2004 .
Another original finding of this work was the reduced concentrations of ET-1 found in the embryos from severely diabetic rats. In mildly diabetic rats, we previously found increased ET-1 levels . As observed with other agents (e.g. superoxide dismutase (Weksler-Zangen et al. 2003) ), ET-1 concentrations may be up-regulated under mild hyperglycemia levels, and its production may be impaired or its concentrations depleted under severe hyperglycemia. ET-1 is clearly involved in the development of structures derived from neural crest cells, including branchial arch-derived craniofacial tissues, great vessels and cardiac outflow structures in rodents and humans (Kurihara et al. 1994 , Brand et al. 1998 , Treinen et al. 1999 . Thus, the reduced ET-1 concentrations in embryos from severely diabetic rats are likely to be involved in the induction of malformations in neural crest-derived organs detected in embryos from diabetic rats and also in infants from diabetic mothers (Ferencz et al. 1990 , Siman et al. 2000 .
Our previous studies have shown that 15dPGJ 2 is generated in the organogenetic embryo and that its levels are reduced in the embryos from mildly diabetic rats (59%, Jawerbaum et al. 2002) . A more marked reduction (92%) and an impairment of the regulation of embryonic NO production was found in this work in the embryos from severely diabetic rats. We have previously found reduced 15dPGJ 2 levels in pancreatic b cells and placenta from diabetic rats, and in term placenta from diabetic patients (Gonzalez et al. 2001 , Jawerbaum et al. 2004 . The multiple biological effects of 15dPGJ 2 , such as its capacity for regulating cell survival, death and differentiation, and its anti-oxidant and antiinflammatory properties, seem to be the result of its interaction with nuclear factors and receptors, including NFkB, PPARg, and nuclear factor-E2-related factor 2 (Straus & Glass 2001 , Levonen et al. 2004 , Lim et al. 2004 . As most of these studies have been conducted in isolated cultured cells, a profound study on the role of 15dPGJ 2 during embryo development will be needed to address the impact of the diminished 15dPGJ 2 concentrations in diabetes-induced congenital malformations.
Our data demonstrated reduced levels of ET-1 and 15dPGJ 2 , and an aberrant nitridergic homeostasis in embryos from severely diabetic rats. The observation of the presence of peroxynitrite-induced damage in those embryos, combined with that of the impairment of regulation of NO production by different developmental signaling molecules, suggests that peroxynitrite could have a major role in diabetic embryopathy. 
